Beware the Dead-Cat Bounce as Cycles Turn Negative for SPX into Late July

Near-term US Equity trends turned last week, and additional weakness looks likely to challenge and undercut last week's lows. While Monday's session bounced back to recover part of Friday's sharp Growth-led decline, the cycle backdrop argues this is more likely a dead-cat bounce than the start of a durable low. My $SPX cycle composite and the 80-day cycle have both rolled over from projected peaks and turned negative between now and at least late July, with a definite possibility of weakness extending into the August-to-October window. The rotation from Growth into Value that arrived Friday should continue, and technically, it still pays to favor the equal-weighted market and the Value, cyclical, and Healthcare groups while stretched momentum names base-build. On the macro side, interest rates look ready to turn down and may begin in earnest after this week's CPI, a move that should prove constructive for Gold and allow the US Dollar to pull back, cushioning risk assets even as Equities chop. It's right to lean cautious in the short run for those with a tactical bent, with a daily close under 7,368 in $SPX likely leading to 7,150–7,250 in the short run and $QQQ targets found near 675.

Monday's rebound looks more like a dead-cat bounce than a durable low

$SPX traded back higher on Monday, recovering roughly 1% to near 7,463 by midday after Friday's Growth-led drop pushed it beneath the 7,516.54 level flagged in Friday's note. While the bounce arrives close to where initial support should have been expected, the cycle backdrop discussed below argues it is more likely a dead-cat bounce than the start of a durable low, and Friday's expansion in volume should not be dismissed. Market breadth proved negative on Monday and both $DJIA and the equal-weighted S&P 500 closed negative on the day. Both $SPX and $QQQ closed down from the opening print and Monday's close sets up for a probable test and undercut of last Friday's lows.

checkout-thomas-lee image
checkout-logo image

Become a Member To Access Fundstrat Research

Fundstrat Direct gives individual investors access to Tom Lee's research, previously only available to banks and hedge funds.

Monthly

$199/mo

First Month Free

Join Now

Annual

-15% $2,028/yr

List Price $2,388

Savings: $360/yr

Join Now

Why Join Fundstrat Direct?

Fundstrat Direct helps you invest confidently with the same research banks and hedge funds use to navigate the market.

Daily Strategy Icon

Daily Strategy from Tom Lee & Team

Stay ahead of consensus with daily updates on key developments & catalysts and opportunities ahead.

Real-Time Market Alerts Icon

Real-Time Market Alerts

Analysis on market-moving events and actionable opportunities delivered instantly from us to you.

Curated Stock Lists Icon

Curated Stock Lists

Choose the portfolio that best suits your investment style, preferred asset class, and time horizon.

Monthly Market Update & Top Ideas Webinar Icon

Monthly Market Update & Top Ideas Webinar

Attend engaging webinars with Tom & team featuring our top ideas and near-term market outlook.

Daily Technical Strategy Icon

Daily Technical Strategy

Receive tactical opportunities, actionable signals, and fundamental analysis from our proven research team.

Live Analysis on Your Holdings Icon

Live Analysis on Your Holdings

A monthly webinar featuring live analysis on member-submitted stocks and questions.

Disclosures (show)

Events

Trending tickers in our research